Selected article for: "abdominal pain and acute covid syndrome"
Author: Lei, Han-Yu; Ding, Ying-He; Nie, Kai; Dong, Yin-Miao; Xu, Jia-Hao; Yang, Meng-Ling; Liu, Meng-Qi; Wei, Le; Nasser, MI; Xu, Lin-Yong; Zhu, Ping; Zhao, Ming-Yi
Title: Potential Effects of SARS-CoV-2 on the Gastrointestinal Tract and Liver
  • Cord-id: rr1ajui4
  • Document date: 2020_11_28
    • ID: rr1ajui4
    Snippet: COVID-19 is a pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Early reported symptoms include fever, cough, and respiratory symptoms. There were few reports of digestive symptoms. However, with COVID-19 spreading worldwide, symptoms such as vomiting, diarrhoea, and abdominal pain have gained increasing attention. Research has found that angiotensin-converting enzyme 2 (ACE2), the SARS-CoV-2 receptor, is strongly expressed in the gastrointestinal tract and liver.
    Document: COVID-19 is a pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Early reported symptoms include fever, cough, and respiratory symptoms. There were few reports of digestive symptoms. However, with COVID-19 spreading worldwide, symptoms such as vomiting, diarrhoea, and abdominal pain have gained increasing attention. Research has found that angiotensin-converting enzyme 2 (ACE2), the SARS-CoV-2 receptor, is strongly expressed in the gastrointestinal tract and liver. Whether theoretically or clinically, many studies have suggested a close connection between COVID-19 and the digestive system. In this review, we summarize the digestive symptoms reported in existing research, discuss the impact of SARS-CoV-2 on the gastrointestinal tract and liver, and determine the possible mechanisms and aetiology, such as cytokine storm. In-depth exploration of the relationship between COVID-19 and the digestive system is urgently needed.

    Search related documents:
    Co phrase search for related documents
    • abdominal discomfort and liver chronic disease: 1
    • abdominal discomfort and liver damage: 1
    • abnormal increase and liver chronic disease: 1, 2
    • abnormal increase and liver damage: 1
    • ace inhibitor and acute increase: 1, 2
    • ace inhibitor and acute sepsis: 1
    • acute increase and liver damage: 1
    • acute sepsis and liver chronic disease: 1, 2, 3, 4
    • acute sepsis and liver damage: 1
    • acute sepsis ards respiratory distress syndrome and liver chronic disease: 1